Sanofi (BIT:1SAN)

Market Cap	99.37B -23.7%
Revenue (ttm)	46.72B +5.5%
Net Income	7.81B +40.5%
EPS	6.40 +44.2%
Shares Out	n/a
PE Ratio	12.72
Forward PE	9.84
Dividend	3.92 (4.89%)
Ex-Dividend Date	May 12, 2025

Volume	2,149
Average Volume	2,567
Open	83.00
Previous Close	82.32
Day's Range	81.26 - 83.00
52-Week Range	76.42 - 111.00
Beta	0.37
RSI	57.64
Earnings Date	Jan 29, 2026

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, that includes hepati...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1994
• Employees: 82,878
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1SAN

Financial Performance

In 2025, Sanofi's revenue was 46.72 billion, an increase of 5.49% compared to the previous year's 44.29 billion. Earnings were 7.81 billion, an increase of 40.52%.